...
首页> 外文期刊>Journal of Clinical Microbiology >A Direct Comparison of Enhanced Saliva to Nasopharyngeal Swab for the Detection of SARS-CoV-2 in Symptomatic Patients
【24h】

A Direct Comparison of Enhanced Saliva to Nasopharyngeal Swab for the Detection of SARS-CoV-2 in Symptomatic Patients

机译:直接比较症状患者中SARS-COV-2检测SARS-COV-2的增强唾液

获取原文
           

摘要

The ongoing coronavirus disease 2019 (COVID-19) pandemic has resulted in shortages of nasopharyngeal swabs (NPS) and viral transport media, necessitating the search for alternate diagnostic specimens, such as saliva. We directly compared matched saliva and NPS specimens from symptomatic patients suspected of having COVID-19. An enhanced saliva specimen (i.e., strong sniff, elicited cough, and collection of saliva/secretions) was collected without transport medium prior to collection of NPS from 224 patients with symptoms deemed consistent with COVID-19. ABSTRACT The ongoing coronavirus disease 2019 (COVID-19) pandemic has resulted in shortages of nasopharyngeal swabs (NPS) and viral transport media, necessitating the search for alternate diagnostic specimens, such as saliva. We directly compared matched saliva and NPS specimens from symptomatic patients suspected of having COVID-19. An enhanced saliva specimen (i.e., strong sniff, elicited cough, and collection of saliva/secretions) was collected without transport medium prior to collection of NPS from 224 patients with symptoms deemed consistent with COVID-19. Both specimens were tested with the CDC 2019 nCoV real-time RT-PCR diagnostic panel (4 February 2020 version), with the NPS result used as the reference standard. For the 216 patients included in the final analysis, there was 100% positive agreement (38/38 positive specimens) and 99.4% negative agreement (177/178 negative specimens). The one discrepant specimen had the presence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) confirmed in the saliva specimen using an alternate FDA EUA assay. The overall mean difference in cycle threshold ( C _(T) ) values for the positive NPS and saliva specimens was ?3.61 (95% confidence interval [CI], ?5.78 to ?1.44; P ?=?0.002). An enhanced saliva specimen performed as well as NPS for the qualitative detection of SARS-CoV-2 in symptomatic patients, although the overall mean viral load in saliva was lower.
机译:正在进行的冠状病毒疾病2019(Covid-19)大流行导致鼻咽拭子(NPS)和病毒传输媒体短缺,需要寻找替代诊断标本,例如唾液。我们直接与涉嫌患有Covid-19的症状患者比较匹配的唾液和NPS标本。在从224例患者中收集与Covid-19一致的症状的患者收集NPS之前,收集了增强的唾液标本(即强烈的嗅探,引发咳嗽和唾液/分泌物的收集)。摘要持续的冠状病毒疾病2019(Covid-19)大流行导致鼻咽拭子(NPS)和病毒传输媒体短缺,这需要寻找替代诊断标本,例如唾液。我们直接与涉嫌患有Covid-19的症状患者比较匹配的唾液和NPS标本。在从224例患者中收集与Covid-19一致的症状的患者收集NPS之前,收集了增强的唾液标本(即强烈的嗅探,引发咳嗽和唾液/分泌物的收集)。用CDC 2019 NCOV实时RT-PCR诊断面板(2月20日版本)进行测试,使用NPS结果作为参考标准。对于最终分析中的216名患者,有100%的阳性协议(38/38阳性标本)和99.4%的负协议(177/178负面标本)。一种差异标本的存在性存在于唾液标本中的严重急性呼吸综合征冠状病毒2(SARS-COV-2),使用替代FDA Eua测定法在唾液标本中证实。阳性NPS和唾液标本的循环阈值(C _(t))值的总体平均差异为3.61(95%置信区间[CI],?5.78至1.44; P?= 0.002)。表现出症状患者中SARS-COV-2的定性检测的增强唾液标本,尽管唾液中的总体平均病毒载量较低。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号